What does left renal pelvicalyceal dilation detected on a fetal growth scan indicate and what potential future complications could arise?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Left Renal Pelvicalyceal Dilation on Fetal Growth Scan

Left renal pelvicalyceal dilation detected on a fetal growth scan represents fluid accumulation in the kidney's collecting system (renal pelvis and calyces), which is the most common finding on prenatal ultrasound occurring in 1-2% of pregnancies and is most often a transient normal variant that resolves spontaneously. 1

What This Finding Means

Pelvicalyceal dilation (also called urinary tract dilation or UTD) refers to enlargement of the kidney's urine collection spaces. The severity is classified based on:

  • Anterior-posterior renal pelvis diameter (APD) measured on ultrasound
  • Gestational age at detection
  • Additional features like calyceal dilation, kidney parenchymal changes, or ureteral dilation

Risk Stratification During Pregnancy

For fetuses less than 28 weeks gestation:

  • APD <4 mm = normal
  • APD 4-7 mm = low risk (UTD A1)
  • APD ≥7 mm = increased risk (UTD A2-3) 1

For fetuses at 28+ weeks gestation:

  • APD <7 mm = normal
  • APD 7-10 mm = low risk (UTD A1)
  • APD ≥10 mm = increased risk (UTD A2-3) 1

Approximately 80% of mild second-trimester dilation (APD 4-8 mm) resolves before birth. 1, 2

Future Problems and Outcomes

Most Common Scenario: Benign Resolution

The vast majority of cases represent transient physiologic dilation with no long-term consequences. If the dilation resolves on follow-up ultrasound after 32 weeks, no postnatal evaluation is needed. 1

Potential Pathologic Causes (Minority of Cases)

When dilation persists or worsens, underlying conditions may include:

Non-obstructive causes:

  • Vesicoureteral reflux (VUR) - most common pathologic cause, occurring in 15-31% of persistent UTD cases 1
  • Transient/physiologic dilation

Obstructive causes:

  • Ureteropelvic junction (UPJ) obstruction - most common obstructive cause
  • Ureterovesical junction obstruction
  • Posterior urethral valves (males)
  • Ureterocele
  • Multicystic dysplastic kidney 1

Specific Risks Based on Severity

Low-risk (UTD A1):

  • Very low risk of urinary tract infection (UTI)
  • Minimal risk of kidney function deterioration
  • Rarely requires surgery 1

Increased-risk (UTD A2-3):

  • 23-64% may develop UTI or require surgery depending on severity 1
  • Higher risk of progressive kidney dysfunction
  • May require antibiotic prophylaxis
  • Closer postnatal monitoring needed 1

Critical threshold: APD ≥15 mm is associated with significantly higher risk of obstruction requiring surgery (sensitivity 73%, specificity 82%). 3, 4

Management Plan

During Pregnancy

If low-risk (UTD A1) detected before 32 weeks:

  • Single follow-up ultrasound at ≥32 weeks gestation
  • If resolved at that scan, no postnatal evaluation needed 1, 2

If increased-risk (UTD A2-3):

  • Serial ultrasounds every 4 weeks
  • Consider prenatal consultation with pediatric urology/nephrology
  • Plan for postnatal follow-up 1

After Birth

Timing of first postnatal ultrasound:

  • Wait until 48 hours after birth (ideally day 7-10) because early scans may underestimate dilation due to normal newborn fluid shifts 1

Based on postnatal ultrasound findings:

UTD P1 (low-risk):

  • Repeat ultrasound at 1-6 months
  • No routine antibiotics
  • No routine VCUG (voiding study) unless UTI occurs 1

UTD P2 (moderate-risk):

  • Repeat ultrasound at 1 month
  • Consider antibiotic prophylaxis (shared decision-making with family)
  • Consider VCUG if ureteral dilation ≥7 mm 1

UTD P3 (high-risk):

  • Repeat ultrasound at 1 month
  • Antibiotic prophylaxis recommended (typically amoxicillin in newborns, then trimethoprim-sulfamethoxazole after 2 months)
  • VCUG recommended
  • Renal functional imaging (MAG3 scan) at 6-12 weeks of age
  • Pediatric urology/nephrology consultation 1

Important Caveats

Aneuploidy Risk

Isolated UTD carries a minimal increased risk for trisomy 21 (positive likelihood ratio 1.5). If no prior aneuploidy screening has been done, cell-free DNA testing or quad screen should be offered, but diagnostic testing (amniocentesis) is not recommended for this finding alone. 2

UTI Vigilance

Any child with known UTD who develops fever should be evaluated for UTI, even if other symptoms suggest a different source. Use catheterized urine specimen if UTI is suspected to avoid contamination. 1

Antibiotic Resistance Concern

Continuous antibiotic prophylaxis increases risk of multidrug-resistant infections by 6.5-9 times, so prophylaxis should be reserved for higher-risk cases and discontinued at 12 months unless high-grade VUR or persistent ureteral dilation ≥7 mm persists. 1

Gender and Circumcision Factors

Males, especially if uncircumcised, have higher UTI risk with UTD. Females with UTD and recurrent UTIs typically have lower-grade VUR with less scarring. 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.